InsiderClue
Stocks · Health care · Pharmaceutical Preparations

COLLEGIUM PHARMACEUTICAL, INC

COLL Clue Score59
United States Fiscal year ends December CIK 0001267565
$22.09 -0.09% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $22.09 +6.25% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.7Operating income−94.1Net income−94.2Fiscal year 2017Revenue28.5 +1,564.3%Operating income−75.4Net income−74.9Fiscal year 2018Revenue280.4 +884.7%Operating income−20.7Net income−39.1EPS, diluted−1.19Fiscal year 2019Revenue296.7 +5.8%Operating income−23.7Net income−22.7EPS, diluted−0.68Fiscal year 2020Revenue310.0 +4.5%Operating income56.2Net income26.8EPS, diluted0.76Fiscal year 2021Revenue276.9 −10.7%Operating income17.6Net income71.5 +167.3%EPS, diluted1.86 +144.7%Fiscal year 2022Revenue463.9 +67.6%Operating income33.3Net income−25.0 −135.0%EPS, diluted−0.74 −139.8%Fiscal year 2023Revenue566.8 +22.2%Operating income167.0Net income48.2EPS, diluted1.29Fiscal year 2024Revenue631.4 +11.4%Operating income169.9Net income69.2 +43.7%EPS, diluted1.86 +44.2%Fiscal year 2025Revenue780.6 +23.6%Operating income179.6Net income62.9 −9.1%EPS, diluted1.73 −7.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.7 28.5 280.4 296.7 310.0 276.9 463.9 566.8 631.4 780.6
Growth +1,564.3% +884.7% +5.8% +4.5% −10.7% +67.6% +22.2% +11.4% +23.6%
Operating income −94.1 −75.4 −20.7 −23.7 56.2 17.6 33.3 167.0 169.9 179.6
Net income −94.2 −74.9 −39.1 −22.7 26.8 71.5 −25.0 48.2 69.2 62.9
Growth +167.3% −135.0% +43.7% −9.1%
EPS, diluted n/a n/a −1.19 −0.68 0.76 1.86 −0.74 1.29 1.86 1.73
Growth +144.7% −139.8% +44.2% −7.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Operating margin−5,498.7%Net margin−5,504.1%Free cash flow margin−4,414.4%Fiscal year 2017Operating margin−264.9%Net margin−262.9%Free cash flow margin−238.8%Fiscal year 2018Gross margin40.9%Operating margin−7.4%Net margin−14.0%Free cash flow margin58.5%Fiscal year 2019Gross margin34.7%Operating margin−8.0%Net margin−7.7%Free cash flow margin7.2%Fiscal year 2020Gross margin58.0%Operating margin18.1%Net margin8.6%Free cash flow margin28.5%Fiscal year 2021Gross margin54.4%Operating margin6.4%Net margin25.8%Free cash flow margin36.7%Fiscal year 2022Gross margin45.2%Operating margin7.2%Net margin−5.4%Free cash flow margin26.4%Fiscal year 2023Gross margin57.5%Operating margin29.5%Net margin8.5%Free cash flow margin48.4%Fiscal year 2024Gross margin59.8%Operating margin26.9%Net margin11.0%Free cash flow margin32.2%Fiscal year 2025Gross margin59.3%Operating margin23.0%Net margin8.1%Free cash flow margin42.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a 40.9% 34.7% 58.0% 54.4% 45.2% 57.5% 59.8% 59.3%
Operating margin −5,498.7% −264.9% −7.4% −8.0% 18.1% 6.4% 7.2% 29.5% 26.9% 23.0%
Net margin −5,504.1% −262.9% −14.0% −7.7% 8.6% 25.8% −5.4% 8.5% 11.0% 8.1%
Free cash flow margin −4,414.4% −238.8% 58.5% 7.2% 28.5% 36.7% 26.4% 48.4% 32.2% 42.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−75.1Capital expenditure−0.5Free cash flow−75.5Fiscal year 2017Operating cash flow−67.0Capital expenditure−1.0Free cash flow−68.0Fiscal year 2018Operating cash flow169.4Capital expenditure−5.5Free cash flow163.9Fiscal year 2019Operating cash flow27.8Capital expenditure−6.4Free cash flow21.3 −87.0%Fiscal year 2020Operating cash flow93.9Capital expenditure−5.5Free cash flow88.4 +314.1%Fiscal year 2021Operating cash flow103.6Capital expenditure−1.9Free cash flow101.6 +15.0%Buybacks−47.9Fiscal year 2022Operating cash flow124.2Capital expenditure−1.6Free cash flow122.6 +20.7%Buybacks−14.1Fiscal year 2023Operating cash flow274.7Capital expenditure−0.5Free cash flow274.3 +123.7%Buybacks−75.0Fiscal year 2024Operating cash flow205.0Capital expenditure−1.7Free cash flow203.3 −25.9%Buybacks−60.0Fiscal year 2025Operating cash flow329.3Capital expenditure−1.7Free cash flow327.6 +61.1%Buybacks−25.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −75.1 −67.0 169.4 27.8 93.9 103.6 124.2 274.7 205.0 329.3
Capital expenditure −0.5 −1.0 −5.5 −6.4 −5.5 −1.9 −1.6 −0.5 −1.7 −1.7
Free cash flow −75.5 −68.0 163.9 21.3 88.4 101.6 122.6 274.3 203.3 327.6
Growth −87.0% +314.1% +15.0% +20.7% +123.7% −25.9% +61.1%
Buybacks n/a n/a n/a n/a n/a −47.9 −14.1 −75.0 −60.0 −25.1

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash153.2Total debt4.1Net cash (debt)149.1Shareholders’ equity134.9Debt to equity0.03Fiscal year 2017Cash118.7Shareholders’ equity104.1Fiscal year 2018Cash146.6Total debt11.5Net cash (debt)135.1Shareholders’ equity91.6Debt to equity0.13Fiscal year 2019Cash170.0Total debt11.5Net cash (debt)158.5Shareholders’ equity87.4Debt to equity0.13Fiscal year 2020Cash174.1Shareholders’ equity186.0Fiscal year 2021Cash186.4Shareholders’ equity202.9Fiscal year 2022Cash173.7Shareholders’ equity194.8Fiscal year 2023Cash238.9Shareholders’ equity195.4Fiscal year 2024Cash70.6Shareholders’ equity228.8Fiscal year 2025Cash231.3Shareholders’ equity301.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 153.2 118.7 146.6 170.0 174.1 186.4 173.7 238.9 70.6 231.3
Total debt 4.1 n/a 11.5 11.5 n/a n/a n/a n/a n/a n/a
Net cash (debt) 149.1 n/a 135.1 158.5 n/a n/a n/a n/a n/a n/a
Shareholders’ equity 134.9 104.1 91.6 87.4 186.0 202.9 194.8 195.4 228.8 301.7
Debt to equity 0.03 n/a 0.13 0.13 n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−75.1 −67.0 169.4 27.8 93.9 103.6 124.2 274.7 205.0 329.3
Growth −83.6% +238.1% +10.2% +20.0% +121.2% −25.4% +60.7%
0.7 0.6 1.1 0.7 n/a n/a n/a n/a n/a n/a
Investment
−0.5 −1.0 −5.5 −6.4 −5.5 −1.9 −1.6 −0.5 −1.7 −1.7
calc −75.5 −68.0 163.9 21.3 88.4 101.6 122.6 274.3 203.3 327.6
Growth −87.0% +314.1% +15.0% +20.7% +123.7% −25.9% +61.1%
calc n/a n/a 4.97 0.64 2.51 2.48 3.62 6.56 5.03 8.25
−3.0 −1.0 −24.4 −6.4 −373.8 −1.9 −573.7 −70.8 −287.8 −63.5
Financing
135.6 33.5 −117.2 2.0 286.5 −89.3 436.7 −140.2 −60.6 −110.2
n/a n/a n/a n/a n/a −47.9 −14.1 −75.0 −60.0 −25.1

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.